Related Experiment Videos
Lipid abnormalities in black renal patients
D E Burrell1, A Antignani, P Goldwasser
1Long Island College Hospital, Avram Center for Kidney Disease, Brooklyn, NY 11201.
Summary
Blacks generally exhibit better cardiovascular risk profiles than whites across various kidney disease stages, including lower total cholesterol and higher HDL-C. Longitudinal studies showed no significant impact of race on lipid profiles over time.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Clinical Biochemistry
Background:
- Racial disparities in lipoprotein (LP) and cardiovascular (CV) abnormalities are recognized in the general and dialysis populations.
- Limited research exists on race-LP-CV interactions within diverse renal disease groups.
Purpose of the Study:
- To investigate racial differences in lipid profiles and CV risk ratios across various chronic kidney disease (CKD) stages.
- To examine longitudinal changes in lipid profiles among end-stage renal disease (ESRD) patients and their relation to race.
Main Methods:
- Cross-sectional analysis of lipid profiles (total cholesterol, HDL-C, apo A-I, apo B) and risk ratios (TC/HDL-C, A-I/B) in patients with normal renal function, nephrotic syndrome, hemodialysis, peritoneal dialysis, post-transplant, and renal insufficiency.
- Longitudinal study of lipid profiles in ESRD patients over four yearly cross-sections, using ANOVA with covariate adjustment.
Main Results:
- Blacks generally showed a more favorable CV risk profile than whites, with lower total cholesterol, higher HDL-C, and better apo ratios across all renal disease groups.
- Whites had lower HDL-C and higher TC/HDL-C ratios than blacks in hemodialysis and CAPD populations.
- Longitudinal analysis revealed no significant effect of race on lipid profiles, though apo B decreased and A-I/B increased over two years.
Conclusions:
- Race is associated with distinct lipid profiles and cardiovascular risk factors across different stages of renal disease.
- While cross-sectional data suggest racial differences, longitudinal studies in ESRD patients did not demonstrate a significant impact of race on lipid profile changes over time.